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S U M M A R Y
Objectives: To investigate the incidence of early-onset neonatal sepsis and identify the main pathogens
over a 5-year period in Kuwait.
Methods: Blood samples were collected from all infants with any clinical or laboratory feature suggestive
of sepsis, at the main maternity hospital in Kuwait. Cases of early-onset neonatal infection were deﬁned
as culture of a single potentially pathogenic organism from blood or cerebrospinal ﬂuid from infants
younger than 7 days of age, in association with clinical or laboratory ﬁndings consistent with infection.
Results: The overall incidence of early-onset neonatal infection was 2.7 (95% conﬁdence interval (CI)
2.3–3.2) episodes per 1000 live-births. The case-fatality was 13.1% (95% CI 8.6–18.9%). Group B
Streptococcus (GBS) accounted for 17.6% of infections among infants younger than 7 days (incidence 0.48
per 1000 live-births), but 38.1% of infections in the ﬁrst 2 days of life. Neither the incidence of early-onset
infection by GBS nor by Escherichia coli changed signiﬁcantly over the study period.
Conclusions: Although the incidence of GBS infections was relatively low, GBS accounted for most early-
onset infections. Intrapartum antibiotic prophylaxis against GBS should be strengthened. There was no
evidence to suggest that early-onset infection due to non-GBS organisms such E. coli has increased in the
last 5 years.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Neonatal deaths account for one third of global child mortality
and infection is the leading cause of death in the neonatal period.1,2
Five years remain to the deadline of the Millennium Development
Goals (MDG), one of which is to reduce the mortality rate among
children under ﬁve by two thirds. The World Health Organization
(WHO) has acknowledged the importance of reducing neonatal
mortality to achieve the MDG and has developed relevant
strategies. However, any attempt to reduce neonatal mortality
requires local and regional knowledge on the incidence, etiological
pattern, and trends in neonatal infections.
Bacterial infection in the early neonatal period is a major cause
of mortality and long-term morbidity.3–9 Its deﬁnition varies from
the presence of a positive blood culture obtained within the ﬁrst 2
days to one obtained within 1 week post-delivery. Early-onset
neonatal sepsis is usually acquired from maternal microorganisms
in the birth canal, rather than from post-partum exposure.10,11 The
leading cause of early-onset neonatal infection is group B* Corresponding author. Tel.: +965 25319920; fax: +965 25338940.
E-mail address: m.hammoud@hsc.edu.kw (M.S. Hammoud).
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doi:10.1016/j.ijid.2011.05.004Streptococcus (GBS), and intrapartum antibiotic prophylaxis is
recommended in the USA for mothers who are at risk of
transmitting GBS infection to their babies during labor.12 Since
intrapartum antibiotic prophylaxis was started in Australia and the
USA, early-onset GBS infections have declined,13–16 but the impact
on other non-GBS infections remains unclear. Concern has arisen
about the possibility that intrapartum antibiotic prophylaxis may
lead to an increase in the incidence of infections by non-GBS
organisms or provoke antibiotic resistance.17 Studies that have
investigated this issue have reported conﬂicting ﬁndings. While
some studies found no evidence that early-onset neonatal
infections caused by non-GBS are increasing,17–21 others have
reported an increase in Escherichia coli infections among low and
very low birth weight infants.22,23 Some reports have also
suggested an increase in the resistance of E. coli to ampicillin,
particularly among premature infants.17–19
Several studies have investigated early-onset neonatal infection
in developing and developed countries. However, few studies have
attempted to describe the pattern of neonatal infection in oil-rich
countries in the Gulf region.24–27 The pattern of organisms causing
neonatal infections changes in the same place over a period of
time.28 The incidence, the main pathogens, and the current trends
in early-onset neonatal infection remain mostly unknown in thisses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Incidence of early-onset neonatal infections among infants aged younger
than 7 days between 2005 and 2009.
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neonatal sepsis and to identify the main pathogens and the trends
over a 5-year period in Kuwait.
2. Materials and methods
Kuwait is a small country with a population of 3.5 million.
Almost all deliveries occur in health facilities, and neonatal and
infant mortality is around 5.6 and 9 per 1000 live-births,
respectively, which is comparable to most developed countries.
The study was conducted at the Kuwait Maternity Hospital, a
major tertiary hospital where approximately one third of all
deliveries in the country occur. There are approximately 12 000
deliveries per year at this hospital. Around 2.5% of all live births are
very low birth weight (1500 g). Since 2005, mothers who are at
risk of GBS infection have received ampicillin as intrapartum
prophylaxis against GBS infection using a risk-based approach.
Antibiotic treatment is initiated immediately among infants with
suspected infection, particularly with the presence of risk factors
such as premature rupture of membranes or maternal fever.
Empirical antibiotic treatment usually starts with ampicillin and
amikacin, but later on the treatment is guided by clinical and
laboratory ﬁndings.
For ﬁve consecutive years, from January 2005 to December
2009, blood samples were collected from all infants with any
clinical or laboratory features suggestive of sepsis. Blood samples
were obtained from a peripheral vein after skin disinfection with
povidone iodine. Blood was cultured using the fully automated
BACTEC blood culture system. Cerebrospinal ﬂuid (CSF) samples
were collected from all infants with culture-proven sepsis or
before the initiation of antimicrobial therapy for clinically
suspected infections.
Data were collected prospectively on sex of the infant,
gestational age, birth weight, age at which the positive blood
culture was obtained, and clinical outcome, using a standard data
collection form. Resistance or susceptibility of the isolated
organisms to various antibiotics was recorded based on the
routine laboratory testing in the hospital.
Cases of early-onset neonatal infection were deﬁned as the
isolation of a single potentially pathogenic organism (bacterium or
fungus) cultured from blood and/or CSF from infants who were
younger than 7 days of age, in association with clinical and/or
laboratory ﬁndings consistent with infection. Cases of meningitis
were deﬁned as CSF culture-positive or blood culture-positive plus
pleocytosis. Likely contaminants were excluded based on the
clinical judgment of the attending neonatologist. Coagulase-
negative staphylococci (CoNS) were considered pathogenic only
if blood culture was positive within 48 h of collection in an infant
with clinical symptoms suggestive of sepsis.
The cumulative incidence per year was calculated by dividing
the number of infections by the number of live births at theTable 1
Organisms causing early-onset infection in the neonatal period in Kuwait, 2005–2009
Organism Age 2 days, n (%) 
Group B Streptococcus 24 (38.1) 
Escherichia coli 8 (12.7) 
Klebsiella 4 (6.4) 
Coagulase-negative staphylococci 5 (7.9) 
Pseudomonas 2 (3.2) 
Acinetobacter 1 (1.6) 
Enterobacter 1 (1.6) 
Staphylococcus aureus 1 (1.6) 
Other Gram-positive bacteria 12 (19.0) 
Other Gram-negative bacteria 5 (7.9) 
Candida 0 (0) 
Total 63 (100) hospital, excluding cases of early-onset infection among infants
admitted from other hospitals (14 infections). Poisson distribution
was used to calculate 95% conﬁdence intervals (95% CI). Chi-square
tests were used to evaluate the differences in proportions for
categorical variables and the Mann–Whitney test was used to test
the difference in medians for continuous variables. Chi-square for
trends was used to test for linear trends in the incidence of early-
onset neonatal infections over the study period. The study was
approved by the ethics committee at the Faculty of Medicine,
Kuwait University.
3. Results
During the 5-year study period, there were 56 134 live births
and a total of 153 episodes of early-onset sepsis were identiﬁed, of
which seven (4.6%) infections were identiﬁed in both blood and
CSF. Of 153 early-onset infections, 83 (54.2%) occurred in males.
The overall incidence in the study period was 2.7 (95% CI 2.3–3.2)
infections per 1000 live-births, with a case-fatality of 13.1% (95% CI
8.6–18.9%). The incidence of early-onset neonatal infections during
the study period is shown in Figure 1.
GBS accounted for 17.6% of all early-onset neonatal infections in
infants younger than 7 days (incidence 0.48 per 1000 live-births),
while E. coli caused 9.8% (see Table 1). However, GBS contributed to
32.0% of neonatal infections among infants in the ﬁrst 3 days of life
and to 38.1% in the ﬁrst 2 days of life (see Table 1). Only three
infections due to GBS occurred among infants 4–7 days of age.
CoNS caused less than 10% of infections in babies less than 2 days of
age. All Gram-negative bacillary infections (i.e., Klebsiella spp, E.
coli, Acinetobacter spp, Pseudomonas spp, Enterobacter spp, and other
Gram-negative bacteria) accounted for 39.2% (n = 60) of infections
among infants younger than 7 days, but 33.3% (n = 21) of infections
among infants in the ﬁrst 2 days of life. There were no Candida
infections among infants in the ﬁrst 3 days of life.Age 3 days, n (%) Age <7 days, n (%)
24 (32.0) 27 (17.6)
8 (10.7) 15 (9.8)
8 (10.7) 23 (15.0)
10 (13.3) 35 (22.9)
2 (2.7) 5 (3.3)
2 (2.7) 8 (5.2)
2 (2.7) 4 (2.6)
1 (1.3) 4 (2.6)
13 (17.3) 20 (13.1)
5 (6.7) 5 (3.3)
0 (0) 7 (4.6)
75 (100) 153 (100)
Figure 2. Incidence of early-onset neonatal infections caused by GBS and non-GBS
bacteria among infants aged younger than 7 days between 2005 and 2009.
Table 2
Characteristics of infants younger than 7 days of age with early-onset neonatal infections (GBS and non-GBS), Kuwait, 2005–2009
Variable GBS (n = 27) Non-GBS (n = 126) p-Value
Sex (male) 51.8% 54.8% 0.800
Gestational age (weeks) Median (IQR) 38.0 (37.0–40.0) 35.0 (30.0–38.0) 0.002
37 81.5% 42.1% 0.001
32–36 7.4% 29.4%
<32 11.1% 28.6%
Birth weight (g) Median (IQR) 2900 (2290–3520) 2125 (1295–3150) 0.008
2500 74.1% 40.5% 0.006
1500–2499 14.8% 27.0%
<1500 11.1% 32.5%
Fatal outcome 7.4% 13.5% 0.58
GBS, group B Streptococcus; IQR, interquartile range.
All % are column percents.
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caused by GBS and non-GBS bacteria over the 5-year period. While
the incidence of non-GBS infection varied from one year to another,
the incidence of GBS infection did not change signiﬁcantly over the
study period (Chi square test for linear trend, p = 0.22). There was no
clear trend in the early-onset neonatal infections caused by E. coli
during the study period. The incidence of early-onset E. coli infection
was 0.17, 0.52, 0.0, 0.27, and 0.37 infections per 1000 live-births in
years 2005, 2006, 2007, 2008, and 2009, respectively (p = 0.78).
Comparison between infants with early-onset neonatal infec-
tions caused by GBS and infants with early-onset infections caused
by non-GBS is shown in Table 2. Infants with early-onset infections
due to GBS were signiﬁcantly more likely to be born after 37 weeks of
gestation and to weigh 2500 g or above when compared to infants
with early-onset infections caused by non-GBS. Case-fatality was
not signiﬁcantly different between early-onset infections caused by
GBS and those caused by non-GBS (7.4% vs. 13.5%; p = 0.58).
Of 27 GBS infections, 17 (63.0%) were resistant to gentamicin,
but all were sensitive to ampicillin and cefotaxime. Of 23 early-
onset infections caused by Klebsiella species, two (8.7%) were
resistant to cefotaxime and three (13.0%) resistant to gentamicin,
but all were resistant to ampicillin. Of 15 early-onset infections
caused by E. coli, 14 (93.3%) were resistant to ampicillin, but only
one (6.7%) was resistant to gentamicin. Of 60 Gram-negative
bacillary infections, 19 (31.6%) were resistant to cefotaxime and six
(10%) were resistant to gentamicin.
4. Discussion
Like other oil-rich countries in the Gulf region, Kuwait has
achieved low infant and neonatal mortality rates, comparable to
developed nations. This study aimed to describe the pattern and
trends of early-onset neonatal infections over a period of 5 years in
Kuwait.During the study period, the overall incidence of culture-proven
early-onset neonatal infection among infants younger than 7 days
was 2.7 infections per 1000 live-births. The incidence was 1.3
infections per 1000 live-births in the ﬁrst 3 days of life and 1.1 per
1000 live-births in the ﬁrst 2 days of life. This is similar to the
incidence reported from developed countries,19,29,30 but lower
than that reported from developing countries such as India28,31,32
and Saudi Arabia.26
In the USA, GBS and E. coli have been recognized as the leading
causes of early-onset neonatal infection.33,34 In our setting, GBS was
also found to be responsible for the majority of early-onset neonatal
infections, particularly those that occurred within the ﬁrst 2 or 3
days of life. However, the incidence of early-onset neonatal infection
due to GBS was comparable to that reported from the USA19,21 and
was less than 0.5 per 1000 live-births from 2007 onwards (see
Figure 2). The incidence of GBS infection did not change signiﬁcantly
between 2005 and 2009. Prior to the implementation of intrapartum
antibiotic prophylaxis against GBS in 2005, the incidence of GBS
infection was estimated to be 1 per 1000 live-births.35With the lack
of rigorous assessment of GBS infection before the implementation
of prophylaxis against GBS, it is not clear how maternal chemopro-
phylaxis has affected the burden of GBS infection in Kuwait. Like
other settings, it is possible that we have underestimated the actual
burden of GBS infection owing to the existence of probable culture-
negative GBS sepsis36,37 as a result of chemoprophylaxis which can
inhibit the growth of GBS in blood and CSF culture.38
In our study, the overall incidence of early-onset neonatal
infection varied from one year to another during the study period,
mainly due to changes in the incidence of infection by CoNS and
other non-GBS bacteria after the second or third day of life. The
increase in the relative importance of CoNS with postnatal age
suggests that these infections are due to post-partum exposure in
the hospital (nosocomial infection) and this probably supports the
deﬁnition of early neonatal infection as that occurring in the ﬁrst 2
days of life.
There is a consensus that intrapartum antibiotic prophylaxis
has reduced the early-onset neonatal infections caused by GBS,14–
16,21 but the impact of this intervention on other causes of neonatal
infection remains unclear.17 One concern is that early-onset
neonatal infections caused by non-GBS organisms may increase as
a result of intrapartum antibiotic prophylaxis. Similar to other
studies,17 our data do not suggest an increase in the incidence of
early neonatal infections due to non-GBS organisms such as E. coli,
although calculations are based on small numbers.
Previous studies have reported an increase in ampicillin-
resistant E. coli particularly among preterm infants17–19 and where
ampicillin is used as intrapartum prophylaxis.21,39 In our setting,
where ampicillin is used in intrapartum prophylaxis, almost all E.
coli infections were resistant to ampicillin. Although we agree with
the comment17,19 that this may reﬂect the overall trend for
antibiotic resistance in the community as a whole, rather than
A. Al-Taiar et al. / International Journal of Infectious Diseases 15 (2011) e631–e634e634being a result of using intrapartum antibiotic prophylaxis, we
support the recent conclusion that obstetricians should consider
preferential use of penicillin G for GBS prophylaxis.21
When we compared GBS infections with non-GBS infections,
GBS infections tended to occur earlier (ﬁrst 2 or 3 days of life) than
non-GBS infections. Furthermore, infants with early-onset infec-
tions caused by non-GBS were more often born before 37 weeks of
gestation and were of low birth weight, whereas early-onset
infections caused by GBS usually affected full-term babies. This
pattern is similar to that reported from other settings.19,34 Unlike
India where Klebsiella and Pseudomonas are the most common
causes of early-onset neonatal infection,28,32 in our study
Klebsiella accounted for approximately 15% of early-onset infec-
tions among infants younger than 7 days, but 6.4% among infants in
the ﬁrst 2 days of life.
It has been suggested that studies based in tertiary units usually
attract high numbers of preterm infants and urban patients of high
socioeconomic status, and are thus not representative of early-
onset neonatal illness at the community level.40 One of the
strengths of our study is that the whole population lives in urban
settings and 100% of births occur in hospitals, one third of which
occur in the study hospital, suggesting high generalizability of the
ﬁndings to Kuwait. It is known that intrapartum prophylaxis with
ampicillin has been recommended since 2005 for all mothers who
are at risk of GBS. One of the limitations of this study is the lack of
data on the actual extent of use of intrapartum antibiotic
prophylaxis during the study period.
In conclusion, although the incidence of early-onset neonatal
infection due to GBS was low in Kuwait and comparable to that in
developed countries, GBS accounted for most early-onset infec-
tions. The incidence of early-onset neonatal infection due to GBS
did not change signiﬁcantly over the study period. Intrapartum
antibiotic prophylaxis against GBS should be audited and possibly
strengthened to further reduce the burden of GBS in Kuwait. There
was no evidence to suggest that early-onset neonatal infection due
to non-GBS organisms such as E. coli has increased in the last 5
years.
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